Publicaciones en colaboración con investigadores/as de Aarhus University Hospital (154)

2024

  1. Correction to: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)

    Nature Reviews Cardiology

  2. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

    Journal of neurology, Vol. 271, Núm. 1, pp. 472-485

  3. Impact of sex on the assessment of the microvascular resistance reserve

    International Journal of Cardiology, Vol. 402

  4. Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 65

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Abnormal physiological findings after FFR-based revascularisation deferral are associated with worse prognosis in women

    Scientific Reports, Vol. 13, Núm. 1

  3. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode

    Liver International, Vol. 43, Núm. 7, pp. 1548-1557

  4. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

    European heart journal, Vol. 44, Núm. 29, pp. 2659-2671

  5. Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry

    International Journal of Cardiology, Vol. 392

  6. Combined use of hyperemic and non-hyperemic pressure ratios for revascularization decision-making: From the ILIAS registry

    International Journal of Cardiology, Vol. 370, pp. 105-111

  7. Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  8. Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    The Lancet Regional Health - Europe, Vol. 33

  9. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

    Gut, Vol. 72, Núm. 4, pp. 749-758

  10. Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements – DEFINE-FLOW core laboratory sub-study

    International Journal of Cardiology, Vol. 377, pp. 9-16

  11. International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design

    American Heart Journal, Vol. 257, pp. 41-50

  12. Microvascular resistance reserve: diagnostic and prognostic performance in the ILIAS registry

    European heart journal, Vol. 44, Núm. 30, pp. 2862-2869

  13. Optical coherence tomography and coronary revascularization: from indication to procedural optimization

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 2, pp. 92-106

  14. Predictors of treatment switching in the Big Multiple Sclerosis Data Network

    Frontiers in Neurology, Vol. 14

  15. Prognostic Implications of Individual and Combinations of Resting and Hyperemic Coronary Pressure and Flow Parameters

    JACC: Asia, Vol. 3, Núm. 6, pp. 865-877

  16. Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 16, pp. e1358-e1364